罗欣药业拟定增股票募资不超8.424亿元

Core Viewpoint - The company, 罗欣药业, has announced a plan to issue A-shares to specific investors, aiming to raise up to 842.4 million RMB for various projects [1] Group 1: Fundraising Details - The issuance will target no more than 35 specific investors, including legal entities, individuals, or other legitimate investment organizations [1] - The total amount to be raised is capped at 842.4 million RMB, which includes the principal amount [1] Group 2: Use of Proceeds - The funds raised will be allocated to several key projects: - Innovative drug research and development projects - Expansion and technical upgrades of raw material drug production facilities - Supplementing working capital [1]